Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: An evolutionary gift for mounting adaptive protection against lung cancer

Dose-Response

Volumn 7, Issue 2, 2009, Pages 104-131

  Scott, Bobby R ^a   Belinsky, Steven A ^a   Leng, Shuguang ^a   Lin, Yong ^a   Wilder, Julie A ^a   Damiani, Leah A ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Adaptive response; Epigenetic reprogramming; Radiation hormesis

Indexed keywords

EID: 70349323627     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.08-016.Scott     Document Type: Article

References (88)

1. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. 1998. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58:5489-5494
2. Bauer G. 2007. Low dose radiation and intercellular induction of apoptosis: potential implications for control of oncogenesis. Int J Radiat Biol 83:873-888
3. Belinsky SA. 2004. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707-717
4. Belinsky SA, Klinge DM, Liechty KC, March TH, Rang T, Gilliland FD, Sotnic N, Adamova G, Rusinova G, Telnov V. 2004. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 25:1063-1067.
5. Belinsky SA. 2005. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26 (9) :1481-1487
6. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy T, Hirsch RF, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. 2006. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 6:3338-3344
7. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21
8. Boreham D, Dolling J, Somers C, Quinn J, Mitchel REJ. 2006. The adaptive response and protection against heritable mutation and fet al. malformations. Dose-Response 4 (4) :317-326
9. Brenner DJ, Hall EJ. 2007. Computed tomography - an increasing source of radiation exposure. N Engl J Med 357:2277-2284
10. Camphausen K, Moses MA, Ménard C, Sproull M, Beecken W-D, Folkman J, O'Reilly MS. 2003. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 63:1990-1993
11. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. 2002. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 160:1823-1830
12. Chen W, Wang X, Zhuang J, Zhang L, Lin Y. 2007. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced apoptosis by quercetin in lung cancer cells. Carcinogenesis 28 (10) :2114-21
13. Collis SJ, Schwaninger JM, Ntambi AJ, Keller TW, Nelson WG, Dillehay LE, DeWesse TL. 2004. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J Biol Chem 279 (48) :49624-49632
14. Cuttler J. 2007. Health effects of low level radiation: when will we acknowledge the reality. Dose- Response 5:292-298
15. Cohen BL. 2008. The linear no-threshold theory of radiation carcinogenesis should be rejected. J Am Physicians Surg 13 (3) :70-76
16. Damiani LA, Yingling CM, Leng S, Romo P, Nakamuar J, Belinsky SA. 2008. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res (in press)
17. Davis S. 1991. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 180:1-12
18. Day T, Zeng G, Hooker A, Bhat M, Scott BR, Turner DR, Sykes PJ. 2007. Adaptive response for chromosomal inversions in pKZ1 mouse prostate induced by low doses of X radiation delivered after a high dose. Radiat Res 167:682-692
19. Draganić IG, Draganić DD, Adioff J-P. 1990. Radiation and Radioactivity. CRC Press, Inc. Boca Raton, Florida.
20. Feinendegen L. 2005. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 78:3-7
21. Feinendegen L. Pollycove M, Neumann RD. 2007. Whole-body responses to low-level radiation exposure: New concepts in mammalian radiobiology. Experim Hematol 35:37-46.
22. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. 2004. H2AX: the histone guardian of the genome. DNA Repair 3:959-067
23. Gamerman D. 1997. Markov Chain Monte Carlo. Stochastic Simulation for Bayesian Inference, Chapman & Hall, London
24. Ghiassi-Nejad M, Zakeri F, Assaei RG, Kariminia A. 2004. Long-term immune and cytogenetic effects of high level natural radiation on Ramsar inhabitants in Iran. J Environ Radioact 74:107-116
25. Gilks WR, Richardson S, Spiegelhalter DJ (editors). 1996. Markov Chain Monte Carlo in Practice, Chapman & Hall, London
26. Hall EJ, Brenner DJ. 2008. Cancer risks from diagnostic radiology. Br J Radiol 81:362-378
27. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermtehylation. N Engl J Med 341 (21) 2042-2054
28. Hipp ML, Bauer G. 1997. Intercellular induction of apoptosis in transformed cells does not depend on p53. Oncogene 17 (7) :791-797
29. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. 1994. Methylation of the estrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540
30. ISU (Idaho State University). 2008. Radioactivity in Nature. Available at: http://physics.isu.edu/radinf/natural.htm
31. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higahimoto Y, Appella E, Yao TP. 2002. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21 (22) :6236-6245
32. Jaworowski Z. 2006. Chernobyl: the fear of the unknown. Atomic Insight Guest Column. Available at http://www.atomicinsights.com/Guests/AGC-05-02-06. html
33. Jemal A, Thomas A, Murray T, Thun M. 2002. Cancer statistics. CA Cancer J Clin 52:23-47.
34. Ju W, Wang X, Chen W, Shi H, Belinsky SA, Lin Y. 2007. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71: 1381-1388
35. Karpinets TV, Foy BD. 2005. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis 26 (8) : 1323-1334
36. Ketchum L. 1987. Lessons of Chernobyl: SNM members try to decontaminate world threatened by fallout. J Nucl Med 28 (6) :933-942
37. Knudson AG. 2001. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162
38. Koturbash I, Rugo RE, Hendricks CA, Loree J, Thibault B, Kutanzi K, Porgribny I, Yanch JC, Endelward BP, Kovalchuk O. 2006. Irradiation induced DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene 25:4267-4275
39. Lenski RE, Barrick JE, Ofria C. 2006. Balancing robustness and evolvability. PLos Biol 4 (12) :2190-2192
40. Liu S. 2003. Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: mechanisms and implications. Nonlin Biol Toxicol Med 1 (1) :71-92
41. Liu S. 2007. Cancer control related to stimulation of immunity by low-dose radiation. Dose-Response 5:39-47
42. Leng S, Stidley CA, Willink R, Bernauer A, Do K, Picchi MA, Sheng X, Franco AM, Berg DVD, Gilliand FD, Zima C, Crowell RE, Belinsky SA. 2008. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res 68 (8) :1-8
43. Luckey T. 1991. Radiation Hormesis. CRC Press, Baca Raton, Ann Arbor, Boston, London.
44. Mancuso M, Pasquali E, Leonardi S, Tanori M, Rebessi S, Di Majo V, Pazzaglia S, Toni MP, Pimpinella M, Covelli V, Saran A. 2008. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. PNAS 105 (34) :12445-12450
45. Masoomi JR, Mohammadi S, Amino M, Ghiassi-Nejad M. 2006. High background radiation areas of Ramsar in Iran: evaluation of DNA damage by alkaline single cell gel electrophoresis (SCGE). J Environ Radioact 86:176-186
46. Mifune M, Sobue T, Arimoto H, Komoto Y, Kondo S, Tanooka H. 1992. Cancer mortality survey in a spa area (Misasa, Japan) with a high radon background. Jpn J Cancer Res 83:1-5
47. Miller G, Martz HF, Little TT, Guilmette RA. 2002. Bayesian internal dosimetry calculations using Markov chain Monte Carlo. Radiat Protect Dosim 98:191-197
48. Mitchel R. 2007. Low doses of radiation reduce risk in vivo. Dose-Response 5:1-10
49. NRC (National Research Council). 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation. Report BEIR-VII, Phase 2, The National Academies Press. Available at: www.nap.edu.
50. Parkin DM, Bray FI, Devesa SS. 2001. Cancer burden in the year 2000.The global picture. Eur J Cancer 37:S4-S66.
51. Portess D, Bauer G, Hill M, O'Neill P. 2007. Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis, Cancer Res 67 (3) :1246-1253
52. Redpath J, Liang D, Taylor T, James C, Christie E, Elmore E. 2001. The shape of the dose-response curve for radiation-induced neoplastic transformation in vitro: evidence for an adaptive response against neoplastic transformation at low doses of low-LET radiation Radiat Res 156:700-707
53. Reik W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 44:425-432
54. Rithidech K, Scott BR. 2008. Evidence for radiation hormesis after in vitro exposure of human lymphocytes to low doses of ionizing radiation, Dose-Response 6:252-271
55. Rothkamm K, Löbrich M. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 100 (9) :5057-5062
56. Russo VEA, Martienssen RA, Riggs AD, eds. 1996. Epigenetic mechanisms of gene regulation. Cold Spring Harbor Laboratory Press, Plainview, NY
57. Sakai K, Hoshi Y, Nomura T, Oda T, Iwasaki T, Fujita K, Yamada T, Tanooka H. 2003. Suppression of carcinogenic process in mice by chronic low dose rate gamma-irradiation, Int J Low Radiat 1 (1) :142-146
58. Sakai K. 2006. Enhancement of bio-protective functions by low dose/dose-rate radiation, Dose- Response 4 (4) :327-332
59. 169Yb gamma radiation, J Nuclear Soc Thailand (in press)
60. Sanders CL and Scott BR. 2008. Smoking and hormesis as confounding factors in radiation pulmonary carcinogenesis. Dose-Response 5:53-79
61. Schwarz SB, Schaffer PM, Kulka U, Ertl-Wagner B, Hell R, Schaffer M. 2008. The effect of radio-adaptive doses on HT29 and GM637 cells. Radiat Oncol 3 (12) :1-6
62. Scott BR. 2004. A biological-based model that links genomic instability, bystander effects, and adaptive response. Mutat Res 568 (1) : 129-143
63. Scott BR. 2005. Stochastic thresholds: A novel explanation of nonlinear dose-response relationships. Dose-Response 3:547-567
64. Scott B, Di Palma J. 2006. Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases, Dose-Response 5:230-255.
65. Scott BR. 2007. Natural background radiation-induced apoptosis and the maintenance of mammalian life on earth. In: LC Vinter (ed.), New Cell Apoptosis Research, pp 1-35. Nova Science Publishers, Inc., Hauppage, NY
66. Scott BR, Haque M, Di Palma J. 2007. Biological basis for radiation hormesis in mammalian cellular communities. Int J Low Radiat 4 (1) :1-16
67. Scott BR. 2008. Low-dose-radiation-stimulated natural chemical and biological protection against lung cancer. Dose-Response 6:299-318.
68. Scott BR, Sanders CL, Mitchel REJ and Boreham DR. 2008. CT scans may reduce rather than increase the risk of cancer. J Am Physicians and Surg 13 (1) :8-11
69. Siva DS. 1998. Data Analysis, a Bayesian Tutorial. Oxford University Press, New York
70. Spiegelhalter D, Thomas A, Best N, Lunn D (editors). 2003. WinBUGS Version 1.4.1, Users Manual. MRC Biostatistics Unit, Cambridge, UK
71. Strzelczyk I, Potter W, Zdrojewicz Z. 2007. Rad-by-rad (bit-by-bit) : Triumph of evidence over activities fostering fear of radiogenic cancer at low doses. Dose-Response 5:275-283
72. Thomas DC, McNeill KG, Dougherty C. 1985. Estimates of lifetime lung-cancer risks resulting from Rn progeny exposures. Health Phys 49:825-846
73. Thompson RE, Nelson DF, Popkin JH, Popkin A. 2008. Case-control study of lung cancer risk from residential radon exposure in Worchester County, Massachusetts. Health Phys 94 (3) :228-241
74. Trosko JE. 1998. Hierarchical and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposure to oxidative stress-inducing agents. Environmental Health Perspect 106, Suppl 1:331-339
75. Tubiana M. 2005. Dose-effect relationship and estimation of the carcinogenic effects of low doses of ionizing radiation: The joint report of the Académie des Sciences (Paris) and of The Académie Nationale de Médicine. Int Radiat Oncol Biol Phys 63 (2) :317-319
76. Tubiana M, Aurengo A, Averbeck D, Bonin A, Le Guen B, Masse R, Monier R, Valleron A-J, de Vathaire F. 2005. Dose-effect relationships and estimation of the carcinogenic effects of low doses of ionizing radiation. Académie des Sciences - Académie Nationale de Médicine Report, Paris, France
77. Tubiana M. 2008. The 2007 Marie Curie prize: the linear no threshold relationship and advance in our understanding of carcinogenesis. Int J Low Radiat 5 (3), in press
78. USEPA (U. S. Environmental Protection Agency). 1993. Home Buyers and Sellers Guide to Radon. Report 402-R-93-003. Available at http://www.radon- levels.com
79. Wang X, Ju W, Renouard J, Aden J, Belinaky A, Lin Y. 2006. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-κB pathway. Cancer Res 66:1089-1095
80. Wang X, Chen W, Lin Y. 2007. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-κB and Akt pathways. Biochem Biophys Res Commun 335:807-812
81. Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, Lin Y. 2008. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Molecular Cancer Therapeutics 7:1156-1163
82. Wilder J, Yuan D. 1995. Regulation of IFN-gamma mRNA production in murine natural killer cells. Int Immunol 7:575-582
83. Wilder JA., Koh CY, Yuan D. 1996. The Role of NK cells during in vivo antigen-specific antibody responses. J Immunol 156:146-152 (Pubitemid 26006957)
84. Wolff S, Afzal V, Wiencke JK, Olivieri G, Michaeli A. 1988. Human lymphocytes exposed to low doses of ionizing radiation become refractory to high doses of radiation as well as to chemical mutagens that induced double-strand breaks in DNA. IntJ Radiat Biol 53 (1) :39-4
85. Wolff S. 1989. Are radiation-induced effects hormetic? Science 245:575-621
86. Wolff S. 1992. Failla memorial lecture. Is radiation all bad? The search for adaptation. Radiat. Res. 131:117-123
87. Wolff S. 1996. Aspects of the adaptive response to very low doses of radiation and other agents. Mutat Res 358:135-142
88. Yuan D, Wilder JA, Dang T, Bennett T, Kumar V. 1992. Activation of B lymphocytes by NK cells. Int. Immunol 4:1373-1380